Sopheon Announces Establishment of Depositary Receipt Share-Trading Facility; Move Enables U.S. Investors to Trade Sopheon Shares in Over-The-Counter Market
MINNEAPOLIS & LONDON--July 25, 2001--Sopheon, the international knowledge management software and services company, announced today that it has established an American Depositary Receipt (ADR) program for Sopheon's shares currently trading on the Alternative Investment Market of the London Stock Exchange (LSE). Sponsored by the Bank of New York, the ADR enables U.S. investors to trade Sopheon shares in the over-the-counter market by purchasing certificates that represent ordinary shares of Sopheon stock. ADRs make trading foreign-based securities easier for U.S. investors through the elimination of many currency exchange, legal, and foreign-ownership transfer obstacles.The ADR details are:
-- | Ratio: 1 ADR = 10 ordinary shares |
-- | Exchange: Nasdaq over-the-counter ("OTC") |
-- | Symbol: SOPEY |
-- | CUSIP: 83577P103 |
Sopheon Chief Financial Officer Arif Karimjee said: "Last year's merger with Teltech has given Sopheon important visibility in the U.S. marketplace and a significant number of U.S. shareholders, including many of our staff. The establishment of an ADR program will facilitate trading of Sopheon shares by U.S. investors."
About Sopheon
Sopheon (LSE:SPE), which last year merged with Minneapolis-based Teltech Resource Network Corporation, is a leading international provider of information and knowledge solutions that enable companies to more efficiently access internal and external information and turn it into the knowledge to compete. Sopheon's experience in integrating information process and content is the foundation for a combination of pre-loaded, industry-specific software applications, expert services and specialized content. Its comprehensive solutions can enhance business processes ranging from product development and customer relationship management to R&D and quality management. Sopheon has operating bases in the United Kingdom, the Netherlands, Germany and the United States. Its clients are companies in the life sciences, high tech and healthcare industry sectors, and include nearly half of the technology-driven companies on the Fortune 500. For more information, please visit www.sopheon.com.